by Truveta Research | Oct 24, 2025 | Featured post, Research, Research Insights
Respiratory virus–associated hospitalizations declined overall in September 2025 (–27.1%). COVID-associated hospitalizations declined substantially (-45.1%) but still account for the most virus-associated hospitalizations in those aged 65 and older (1.1%). Rhinovirus...
by Truveta Research | Oct 21, 2025 | Research, Research Insights
In patients with CKD and diabetes, anemia prevalence and severity increased from stage 1 to stage 5, with overall anemia rising from 46.4% to 85.0% and severe anemia from 2.5% to 11.8% Erythropoiesis-stimulating agents (ESAs) and IV iron use rose as hemoglobin levels...
by Truveta Research | Oct 20, 2025 | Research, Research Insights
Overall GLP-1 prescribing rates (GLP-1 RA prescriptions per total prescriptions) in September 2025 remained stable relative to June 2025 (+4.6%). As of September 2025, GLP-1 prescriptions account for 6.5 out of every 100 prescriptions in the US. Tirzepatide continues...
by Truveta Research | Oct 17, 2025 | Research, Research Insights
Nearly half of patients with gestational diabetes mellitus (GDM) received nutrition counseling within 45 days of diagnosis, while smaller proportions initiated insulin (15%) or metformin (10%). Despite being the first-line intervention, about half of patients with GDM...
by Truveta Research | Oct 17, 2025 | Research, Research Insights
Nearly one-quarter of patients exceeded the 140 mg/dL threshold on the 1-hour glucose tolerance test. However, about 1 in 10 patients with elevated values did not receive recommended follow-up testing or a GDM diagnosis, highlighting gaps in adherence to clinical...
by Truveta Research | Oct 2, 2025 | Research, Research Insights
Authors: Authors: Nina B Masters, PhD, MPH ⊕Truveta, Inc, Bellevue, WA, Karen Gilbert Farrar, PhD ⊕Truveta, Inc, Bellevue, WA, Duy Hoang, PhD ⊕Truveta, Inc, Bellevue, WA, Brianna M Cartwright, MS ⊕Truveta, Inc, Bellevue, WA Mothers who gained more weight during...
